Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02330419 · ClinicalTrials.gov registry record · Phase 2
Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT02330419 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 120 participants.
The verdict
NCT02330419, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
This is a double-blind, placebo-controlled trial of 120 binge-drinking MSM to 12 weeks of naltrexone 50mg, to be taken in anticipation of heavy drinking. Ethnically and racially diverse participants will be recruited using Respondent Driven Sampling as well as active field recruitment. MSM will be seen weekly for alcohol-metabolite urine testing, study drug dispensing, and brief counseling for alcohol use. Safety assessments and behavioral surveys will be completed monthly.
Interventions
- DRUG Placebo
- DRUG Naltrexone
- BEHAVIORAL Medical Management (MM) counseling for alcohol use:
- DIAGNOSTIC_TEST Urinalysis for novel alcohol biochemical markers:
- BEHAVIORAL Behavioral survey measurements:
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-04 |
| Est. Completion | 2021-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02330419
The ClinicalTrials.gov registry entry for NCT02330419 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT02330419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02330419 about?
NCT02330419 is a clinical study titled "Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)". This is a double-blind, placebo-controlled trial of 120 binge-drinking MSM to 12 weeks of naltrexone 50mg, to be taken in anticipation of heavy drinking. Ethnically and racially diverse participants will be recruited using Respondent Driven Sampling as well as active field recruitment. MSM will be s...
What is the current status of trial NCT02330419?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2015-04. Estimated completion is 2021-01.
What interventions are being tested in trial NCT02330419?
The interventions under investigation include: Placebo (DRUG), Naltrexone (DRUG), Medical Management (MM) counseling for alcohol use: (BEHAVIORAL), Urinalysis for novel alcohol biochemical markers: (DIAGNOSTIC_TEST), Behavioral survey measurements: (BEHAVIORAL).
Who is sponsoring clinical trial NCT02330419?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.